RET-IN-8
RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1].
Product Specifications
CAS Number
2642164-75-6
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-8.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=CC=C(N4CCN(C([C@H](O)C(C)C)=O)CC4)N=C3)=CC(C5=CCOCC5)=CN2N=C1
Molecular Formula
C27H30N6O3
Molecular Weight
486.57
References & Citations
[1]Gou J, et, al. Pyrazole[1,5-a]pyridine-3-nitrile compound and pharmaceutical use thereof. WO2021093720A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6453554-01 0.1 mL
SERPINB10 (SERPINB 10, SERPINB-10, Serine Protease Inhibitor B10) (PE)
Sign In for Pricing
View Details MBS6453554-02 5x 0.1 mL
SERPINB10 (SERPINB 10, SERPINB-10, Serine Protease Inhibitor B10) (PE)
Sign In for Pricing
View Details 
MBS6318254-01 0.2 mL
MAP1ALC3, cleaved (LC3B, MAP1LC3B, Microtubule-associated proteins 1A/1B light chain 3B, Autophagy-related protein LC3 B, Autophagy-related ubiquitin-like modifier LC3 B, MAP1 light chain 3-like protein 2, MAP1A/MAP1B light chain 3 B, Microtubule-associat
Sign In for Pricing
View Details